Diamond Therapeutics
PrivateLast Round
Grant
May 11, 2026
Total Funding Raised
$8.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Diamond Therapeutics is a biotechnology company that develops sub-perceptual, non-hallucinogenic psychedelic-based medicines for the treatment of mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diamond Therapeutics Comparables
Compare Diamond Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transneural Therapeutics, Inc. | 86% | |
| Delix Therapeutics | 85% | |
| Xylo Bio | 83% |
Diamond Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 11, 2026 | ||||
| Seed | Apr 4, 2023 | ||||
| Convertible Debt | Jan 7, 2021 | ||||
| Seed | Apr 1, 2020 |
Key People
Founding team and executive leadership
Diamond Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Convertible Debt |
| ARPA-H | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 255% MoM, reaching 703.
- May 11, 2026
$4M grant from ARPA-H
Diamond Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Diamond Therapeutics's valuation, stock price, and market status.
Is Diamond Therapeutics a public or private company?
Diamond Therapeutics is a private company.
What is the current stock price of Diamond Therapeutics?
Diamond Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Diamond Therapeutics worth (valuation)?
Valuation information for Diamond Therapeutics is not publicly available.
Can I buy Diamond Therapeutics stock?
Diamond Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Diamond Therapeutics's last funding round?
Diamond Therapeutics's most recent funding round was Grant on May 11, 2026.
Who are the main investors in Diamond Therapeutics?
Key investors in Diamond Therapeutics include Ontario Brain Institute, ARPA-H.
Will Diamond Therapeutics IPO soon?
No public IPO plans have been announced for Diamond Therapeutics.
How can I track Diamond Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Diamond Therapeutics's secondary market activity and sign up for updates.